-
1
-
-
0020518953
-
Thrombosis, abortion, cerebral disease and lupus anticoagulant
-
Hughes GRV. Thrombosis, abortion, cerebral disease and lupus anticoagulant. Br Med J 1983; 187: 1088-1089.
-
(1983)
Br Med J
, vol.187
, pp. 1088-1089
-
-
Hughes, G.R.V.1
-
2
-
-
0024428788
-
The 'primary' antiphospholipid syndrome: Major clinical and serological features
-
Asherson RA, Khamashta MA, Ordi-Ros J et al. The 'primary' antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989; 68: 366-374.
-
(1989)
Medicine (Baltimore)
, vol.68
, pp. 366-374
-
-
Asherson, R.A.1
Khamashta, M.A.2
Ordi-Ros, J.3
-
3
-
-
0026322836
-
Induction of anti-phospholipid syndrome by passive transfer of anti-cardiolipin antibodies
-
Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of anti-phospholipid syndrome by passive transfer of anti-cardiolipin antibodies. Proc Natl Acad Sci 1991; 88: 3069-3073.
-
(1991)
Proc Natl Acad Sci
, vol.88
, pp. 3069-3073
-
-
Blank, M.1
Cohen, J.2
Toder, V.3
Shoenfeld, Y.4
-
4
-
-
0026663398
-
Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anti-cardiolipin antibody (H-3)
-
Bakimer R, Fishman P, Blank M, Sredni B, Djaldetti M, Shoenfeld Y. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anti-cardiolipin antibody (H-3). J Clin Invest 1992; 89: 1558-1663.
-
(1992)
J Clin Invest
, vol.89
, pp. 1558-1663
-
-
Bakimer, R.1
Fishman, P.2
Blank, M.3
Sredni, B.4
Djaldetti, M.5
Shoenfeld, Y.6
-
5
-
-
0026457786
-
The putative role of cytokines in the induction of primary antiphospholipid syndrome
-
Fishman P, Bakimer R, Blank M, Sredni D, Djaldetti M, Shoenfeld Y. The putative role of cytokines in the induction of primary antiphospholipid syndrome. Clin Exp Immunol 1992; 90: 266-270.
-
(1992)
Clin Exp Immunol
, vol.90
, pp. 266-270
-
-
Fishman, P.1
Bakimer, R.2
Blank, M.3
Sredni, D.4
Djaldetti, M.5
Shoenfeld, Y.6
-
6
-
-
0028045047
-
Induction of experimental antiphospholipid syndrome in naive mice with purified IgG antiphosphatidylserine antibodies
-
Blank M, Tincani A, Shoenfeld Y. Induction of experimental antiphospholipid syndrome in naive mice with purified IgG antiphosphatidylserine antibodies. J Rheumatol 1994; 21: 100-104.
-
(1994)
J Rheumatol
, vol.21
, pp. 100-104
-
-
Blank, M.1
Tincani, A.2
Shoenfeld, Y.3
-
7
-
-
0028365677
-
Induction of tissue factor like activity in monocytes by anti-cardiolipin antibodies
-
Kronenberg A, Blank M, Kaufman S, Shoenfeld Y. Induction of tissue factor like activity in monocytes by anti-cardiolipin antibodies. J Immunol 1994; 153: 1328-1332.
-
(1994)
J Immunol
, vol.153
, pp. 1328-1332
-
-
Kronenberg, A.1
Blank, M.2
Kaufman, S.3
Shoenfeld, Y.4
-
8
-
-
0028169961
-
2GP-I) induces experimental antiphospholipid syndrome in naive mice
-
2GP-I) induces experimental antiphospholipid syndrome in naive mice. J Autoimmun 1994; 7: 441-455.
-
(1994)
J Autoimmun
, vol.7
, pp. 441-455
-
-
Blank, M.1
Faden, D.2
Tincani, A.3
-
9
-
-
0027242331
-
In vitro effect of anticardiolipin autoantibodies upon total and pulsatile placental hCG secretion during early pregnancy
-
Shurtz-Swirsky R, Inbar O, Blank M et al. In vitro effect of anticardiolipin autoantibodies upon total and pulsatile placental hCG secretion during early pregnancy. Am J Reprod Immunol 1993; 29: 206-210.
-
(1993)
Am J Reprod Immunol
, vol.29
, pp. 206-210
-
-
Shurtz-Swirsky, R.1
Inbar, O.2
Blank, M.3
-
10
-
-
0027328154
-
Prevention of fetal loss in experimental antiphospholipid syndrome by low molecular weight heparin
-
Inbar O, Blank M, Faden D, Tincani A, Lorber M, Shoenfeld Y. Prevention of fetal loss in experimental antiphospholipid syndrome by low molecular weight heparin. Am J Obstet Gynecol 1993; 169: 423-426.
-
(1993)
Am J Obstet Gynecol
, vol.169
, pp. 423-426
-
-
Inbar, O.1
Blank, M.2
Faden, D.3
Tincani, A.4
Lorber, M.5
Shoenfeld, Y.6
-
11
-
-
0027219044
-
The effect of aspirin on recurrent fetal loss in experimental antiphospholipid syndrome
-
Krause I, Blank M, Gilburd B, Shoenfeld Y. The effect of aspirin on recurrent fetal loss in experimental antiphospholipid syndrome. Am J Reprod Immunol 1993; 29: 155-161.
-
(1993)
Am J Reprod Immunol
, vol.29
, pp. 155-161
-
-
Krause, I.1
Blank, M.2
Gilburd, B.3
Shoenfeld, Y.4
-
12
-
-
0027159105
-
Prevention of fetal-loss in experimental anti-phospholipid syndrome by in vivo administration of recombinant interleukin-3
-
Fishman P, Falach-Vaknine E, Zigelman R et al. Prevention of fetal-loss in experimental anti-phospholipid syndrome by in vivo administration of recombinant interleukin-3. J Clin Invest 1993; 91: 1834-1837.
-
(1993)
J Clin Invest
, vol.91
, pp. 1834-1837
-
-
Fishman, P.1
Falach-Vaknine, E.2
Zigelman, R.3
-
13
-
-
0028172240
-
Effect of long acting thromboxane receptor antagonist (BMS 180,291) on experimental antiphospholipid syndrome
-
Shoenfeld Y, Blank M. Effect of long acting thromboxane receptor antagonist (BMS 180,291) on experimental antiphospholipid syndrome. Lupus 1994; 3: 397-400.
-
(1994)
Lupus
, vol.3
, pp. 397-400
-
-
Shoenfeld, Y.1
Blank, M.2
-
14
-
-
0036196287
-
Bacterial induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome
-
Blank M, Krause AI, Fridkin M et al. Bacterial induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 2002; 109: 797-804.
-
(2002)
J Clin Invest
, vol.109
, pp. 797-804
-
-
Blank, M.1
Krause, A.I.2
Fridkin, M.3
-
15
-
-
0033609058
-
Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides
-
Blank M, Shoenfeld Y, Cabilly S, Heldman Y, Fridkin M, Katchalski-Katzir E. Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. Proc Natl Acad Sci USA 1999; 96: 5164-5168.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 5164-5168
-
-
Blank, M.1
Shoenfeld, Y.2
Cabilly, S.3
Heldman, Y.4
Fridkin, M.5
Katchalski-Katzir, E.6
-
16
-
-
0037859220
-
Antiphospholipid antibodies in human and murine atherosclerosis
-
Asherson RA, Cervera R, Piette JC, Shoenfeld Y (eds), Elsevier: Amsterdam
-
Sherer Y, Shoenfeld Y. Antiphospholipid antibodies in human and murine atherosclerosis. In: Asherson RA, Cervera R, Piette JC, Shoenfeld Y (eds). The antiphospholipid syndrome II, Elsevier: Amsterdam, 2002, pp 137-141.
-
(2002)
The Antiphospholipid Syndrome II
, pp. 137-141
-
-
Sherer, Y.1
Shoenfeld, Y.2
-
17
-
-
0004276177
-
-
CRC Press, Boca Raton, FL
-
Asherson RA, Cervera R, Piette JC, Shoenfeld Y (eds). The antiphospholipid syndrome. CRC Press, Boca Raton, FL, 2000.
-
(2000)
The Antiphospholipid Syndrome
-
-
Asherson, R.A.1
Cervera, R.2
Piette, J.C.3
Shoenfeld, Y.4
-
19
-
-
0012082809
-
-
Elsevier: Amsterdam
-
Asherson RA, Cervera R, Piette JC, Shoenfeled Y (eds). The antiphospholipid syndrome II, autoimmune thrombosis. Elsevier: Amsterdam, 2002, pp 1-457.
-
(2002)
The Antiphospholipid Syndrome II, Autoimmune Thrombosis
, pp. 1-457
-
-
Asherson, R.A.1
Cervera, R.2
Piette, J.C.3
Shoenfeled, Y.4
-
21
-
-
0028908094
-
The management of thrombosis in the antiphospholipidantibody syndrome
-
Khamashta MA, Quadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR. The management of thrombosis in the antiphospholipidantibody syndrome. New Engl J Med 1995; 332(15):993-997.
-
(1995)
New Engl J Med
, vol.332
, Issue.15
, pp. 993-997
-
-
Khamashta, M.A.1
Quadrado, M.J.2
Mujic, F.3
Taub, N.A.4
Hunt, B.J.5
Hughes, G.R.6
|